UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Blood, 2010-10, Vol.116 (14), p.2582-2589

2010

Volltextzugriff (PDF)

Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

Hematology/oncology clinics of North America, 2010-12, Vol.24 (6), p.1089-1107

2010

Volltextzugriff (PDF)

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Journal of bone and mineral research, 2009-03, Vol.24 (3), p.543-557

2009

Volltextzugriff (PDF)

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

PloS one, 2012-03, Vol.7 (3), p.e32345-e32345

2012

Volltextzugriff (PDF)

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Haematologica (Roma), 2013-01, Vol.98 (1), p.129-135

2013

Volltextzugriff (PDF)

Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis

Blood, 2011-01, Vol.117 (4), p.1379-1389

2011

Volltextzugriff (PDF)

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature medicine, 2013-04, Vol.19 (4), p.437-445

2013

Volltextzugriff (PDF)

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

The Journal of clinical investigation, 2010-12, Vol.120 (12), p.4466-4477

2010

Volltextzugriff (PDF)

Combined iron chelation therapy

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.79-86

2010

Volltextzugriff (PDF)

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Blood, 2007-06, Vol.109 (11), p.5027-5035

2007

Volltextzugriff (PDF)

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

British journal of haematology, 2009-09, Vol.146 (5), p.546-556

2009

Volltextzugriff (PDF)

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Blood, 2008-08, Vol.112 (3), p.875-885

2008

Volltextzugriff (PDF)

Effect of Transfusional Iron Overload on Immune Response

The Journal of infectious diseases, 2000-09, Vol.182 (Supplement-1), p.S115-S121

2000

Volltextzugriff (PDF)

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

The Lancet (British edition), 2003-05, Vol.361 (9369), p.1597-1602

2003

Volltextzugriff (PDF)

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Blood cells, molecules, & diseases, 2010-08, Vol.45 (2), p.136-139

2010

Volltextzugriff (PDF)

Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials

Blood cells, molecules, & diseases, 2011-10, Vol.47 (3), p.166-175

2011

Volltextzugriff (PDF)

Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling

Blood, 2012-03, Vol.119 (13), p.3187-3189

2012

Volltextzugriff (PDF)

Iron metabolism and ineffective erythropoiesis in β-thalassemia mouse models

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.24-30

2010

Volltextzugriff (PDF)

Hepcidin and Hfe in iron overload in β-thalassemia

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.221-225

2010

Volltextzugriff (PDF)

Phase Ib clinical trial of starch‐conjugated deferoxamine (40SD02): a novel long‐acting iron chelator

British journal of haematology, 2007-08, Vol.138 (3), p.374-381

2007

Volltextzugriff (PDF)

Chelation therapy in β-thalassemia: An optimistic update

Seminars in hematology, 2001-10, Vol.38 (4), p.360-366

2001

Volltextzugriff (PDF)

Changes in Bone Microarchitecture and Biomechanical Properties in the th3 Thalassemia Mouse are Associated with Decreased Bone Turnover and Occur During the Period of Bone Accrual

Calcified tissue international, 2010-06, Vol.86 (6), p.484-494

2010

Volltextzugriff (PDF)

Increased leucocyte apoptosis in transfused β‐thalassaemia patients

British journal of haematology, 2013-02, Vol.160 (3), p.399-403

2013

Volltextzugriff (PDF)

Exploring the Role of Hepcidin, an Antimicrobial and Iron Regulatory Peptide, in Increased Iron Absorption in β-Thalassemia

Annals of the New York Academy of Sciences, 2005-11, Vol.1054 (1), p.417-422

2005

Volltextzugriff (PDF)

Antiretroviral Effects of Deoxyhypusyl Hydroxylase Inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (hiv-1)

Biochemical pharmacology, 1998-06, Vol.55 (11), p.1807-1818

1998

Volltextzugriff (PDF)

1 – 25 von 322

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(267)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(322)
Japanisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

Combined iron chelation therapy

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Effect of Transfusional Iron Overload on Immune Response

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials

Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling

Iron metabolism and ineffective erythropoiesis in β-thalassemia mouse models

Hepcidin and Hfe in iron overload in β-thalassemia

Phase Ib clinical trial of starch‐conjugated deferoxamine (40SD02): a novel long‐acting iron chelator

Chelation therapy in β-thalassemia: An optimistic update

Changes in Bone Microarchitecture and Biomechanical Properties in the th3 Thalassemia Mouse are Associated with Decreased Bone Turnover and Occur During the Period of Bone Accrual

Increased leucocyte apoptosis in transfused β‐thalassaemia patients

Exploring the Role of Hepcidin, an Antimicrobial and Iron Regulatory Peptide, in Increased Iron Absorption in β-Thalassemia

Antiretroviral Effects of Deoxyhypusyl Hydroxylase Inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (hiv-1)

Suchergebnisse filtern